13F Holdings
中文EN

BIOX Bioceres Crop Solutions Corp. IFRS

Agricultural Chemicals · Nasdaq · SEC CIK 1769484 · Fiscal year ends 06/30

Financial factors as of 2025-12-31 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-28.4%
TTM net income YoY-16,023.8%
TTM EPS YoY-9,660.3%
Revenue 3-yr CAGR-10.3%
Net income 3-yr CAGR—

Margins

Gross margin39.1%
Operating margin0.8%
Net margin-83.4%
FCF margin27.7%
EBITDA margin—

Returns

ROE-123.8%
ROA-34.2%
ROIC (approx.)0.5%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets81.0%
Debt / equity1.63x
Current ratio0.90x
Interest coverage0.07x

Cash quality & payout

Operating cash flow / net income-0.34x
Accruals ratio-46.0%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30FY20212021-06-30
Income statement
Revenue$335.11M$464.78M$420.06M$334.84M$209.53M
Cost of revenue$203.42M$278.22M$235.46M$208.36M$118.64M
Gross profit$131.68M$186.56M$184.60M$126.48M$90.88M
R&D expense$14.91M$17.18M$15.35M$6.95M$5.62M
SG&A expense$123.11M$123.69M$113.00M$77.48M$47.60M
Operating income-$2.24M$45.85M$54.18M$39.87M$38.38M
Interest expense$28.84M$26.87M$23.79M$17.93M$21.24M
Pretax income-$57.57M$11.07M$19.11M$14.06M$10.53M
Income tax$1.27M$3.78M-$1.07M$17.97M$14.35M
Net income-$55.42M$4.28M$18.78M-$7.20M-$6.87M
EPS (basic)-0.880.070.30-0.17-0.18
EPS (diluted)-0.880.070.30-0.17-0.18
Weighted avg. shares (diluted)63.23M63.49M63.19M42.30M39.22M
Balance sheet
Cash & equivalents$32.70M$44.47M$48.13M$33.48M$36.05M
Short-term investments——$212,703$265,123$425,976
Receivables$165.86M$207.32M$158.01M$111.75M$88.78M
Inventory$87.61M$125.93M$140.43M$126.04M$61.04M
Current assets$308.31M$408.67M$397.11M$297.71M$211.49M
PP&E, netmay include right-of-use assets (IFRS)$74.58M$74.57M$67.85M$49.91M$47.95M
Goodwill$112.16M$112.16M$112.16M$36.07M$28.75M
Intangibles$181.17M$176.89M$173.78M$76.70M$67.34M
Total assets$763.65M$852.55M$818.06M$518.22M$394.59M
Current liabilities$337.99M$329.31M$298.71M$222.67M$168.04M
Short-term debt$119.73M$136.75M$107.64M$71.30M$76.79M
Long-term debt$38.20M$42.10M$60.67M$74.18M$47.99M
Total debt$157.93M$178.85M$168.31M$145.48M$124.77M
Total liabilities$468.43M$501.17M$487.56M$359.92M$304.30M
Shareholders' equity$265.44M$315.04M$298.59M$127.36M$67.74M
Net debt$125.23M$134.38M$120.18M$112.00M$88.73M
Cash flow statement
Operating cash flow$49.91M$41.72M$2.59M-$17.52M-$6.21M
Capital expenditure$5.64M$9.79M$11.36M$3.46M$2.81M
Free cash flow$44.26M$31.93M-$8.77M-$20.97M-$9.01M
Investing cash flow-$6.13M-$28.73M-$25.73M$2.90M-$8.31M
Financing cash flow-$50.71M-$10.06M$32.95M$14.82M$7.36M
Stock-based compensation$4.39M$14.13M$3.42M$1.43M$1.66M
Dividends paid$72,051$174,800$452,129——
Share buybacks$926,899$734,388$3.00M—$3.50M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.